Biotech

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 24.10.2022.

Medicine
Therapy
Pharmacology
Virus
Clinical trial protocol
The Canon of Medicine

@BIODeutschland shared
On Oct 18, 2022
RT @CardiorPharma: Cardior CSO @ThomasThum_Lab is presenting today at the #RNA Leaders USA Congress by @LSXLeaders on how non-coding RNA-based therapeutics can trigger a paradigm shift in treating heart diseases. For more info visit: https://t.co/lgIrnHaZhX https://t.co/8h7LBShL7c
Open
Congress agenda

Congress agenda

The RNA Leaders USA Congress delivers the latest advances in RNA chemistry, clinical updates, new therapies and the services partners who are helping to deliver drugs to patients.

@matthewherper shared
On Oct 24, 2022
Sumitomo clinches Myovant buyout after upping offer to $2.9B https://t.co/4FCFZIYBsw
Open
Sumitomo clinches Myovant buyout after upping offer to $2.9B

Sumitomo clinches Myovant buyout after upping offer to $2.9B

A few weeks after balking at a buyout offer, Myovant Sciences appears to have successfully negotiated upward. The former Vivek Ramaswamy company accepted a deal from its majority owner ...

@matthewherper shared
On Oct 23, 2022
In the room when a clinical trial fails, by @avaskham "The room fell silent... Levin began to cry. His colleagues, many of whom had also devoted years of their lives to this project, cried too." https://t.co/RxYaEapul1
Open
What next for Angelman?

What next for Angelman?

After gaboxadol’s failure, Ovid and others are investigating new drug modalities for Angelman syndrome.

@BIODeutschland shared
On Oct 18, 2022
Atriva Therapeutics announces appointment of CSO and senior leaders to Clinical Development Team https://t.co/ePB9tk0xIZ
Open
Atriva Therapeutics announces appointment of CSO and senior leaders to Clinical Development Team

Atriva Therapeutics announces appointment of CSO and senior leaders to Clinical Development Team

Today, Atriva Therapeutics announced three key appointments in their science and clinical development departments.

@Biotechnology shared
On Oct 24, 2022
LAXAI Receives Investment from SIGNET Healthcare Partners LAXAI Inc. announced that it has received a growth capital investment from SIGNET Healthcare Partners, a New York-based healthcare private equity firm. Syncona to Acquire Applied Genetic… https://t.co/bZ8AuVQgMl
Open
LAXAI Receives Investment from SIGNET Healthcare Partners

LAXAI Receives Investment from SIGNET Healthcare Partners

LAXAI Receives Investment from SIGNET Healthcare Partners - read this article along with other careers information, tips and advice on BioSpace

@BIODeutschland shared
On Oct 20, 2022
Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy https://t.co/asyZSjNPMV
Open
Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy

Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy

Agreement Adds Third Investigational Therapy to Takeda’s Pipeline for the Potential Treatment of Celiac Disease OSAKA, Japan, and FREIBURG and DARMSTADT, Germany, October 20, 2022 …

@BIODeutschland shared
On Oct 20, 2022
Atriva Therapeutics to take part in upcoming industry and investor conferences https://t.co/d17dJ0JdiJ
Open
Atriva Therapeutics to take part in upcoming industry and investor conferences

Atriva Therapeutics to take part in upcoming industry and investor conferences

Today, Atriva Therapeutics announced its participation in upcoming industry and investor conferences.

Read more:
weekly 24.10.2022
View archives
Back to home

Subscribe to Biotech - Biotech & Healthcare.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Biotech & Healthcare.
Privacy Policy

Sign up for the weekly Biotech - Biotech & Healthcare newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Biotech & Healthcare weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy